NuVasive contends that Globus Medical’s LLIF lateral fusion offering — including instrumentation, implants and techniques under the trademarks of TransContinental, MARS 3V and LLIF — infringe on NuVasive’s XLIF intellectual property. The XLIF is a procedure for minimally invasive lumbar fusions.
Globus Medical has not responded to the NuVasive lawsuit.
Read the NuVasive release on patent infringement.
Read other coverage on NuVasive:
– Two Insurers Reverse Policies to Cover Procedures
– NuVasive Reports 2Q Revenue Up 35.2%
– Vail-Summit Spine Surgoen First to Use MAS-TLIF for Minimally Invasive Spine Fusion
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
